Actinogen Medical (ASX:ACW) YoY EPS Growth : 50.00% (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Actinogen Medical's YoY EPS Growth for the quarter that ended in Dec. 2024 was 50.00%.

Actinogen Medical's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was A$-0.00.

Actinogen Medical YoY EPS Growth Historical Data

The historical data trend for Actinogen Medical's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical YoY EPS Growth Chart

Actinogen Medical Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

YoY EPS Growth

Get a 7-Day Free Trial

50.00

25.00

-66.67

-20.00

Actinogen Medical Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EPS Growth	Get a 7-Day Free Trial															-33.33	-	-50.00	100.00	50.00

Actinogen Medical YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Actinogen Medical's YoY EPS Growth for the fiscal year that ended in Jun. 2024 is calculated as:

	YoY EPS Growth (A: Jun. 2024 )
=	(Earnings per Share (Diluted) (A: Jun. 2024 )	-	Earnings per Share (Diluted) (A: Jun. 2023 ))	/	\| Earnings per Share (Diluted) (A: Jun. 2023 ) \|
=	(-0.006	-	-0.006)	/	\| -0.006 \|
=	0.00 %

Actinogen Medical's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (Q: Dec. 2024 )
=	(Earnings per Share (Diluted) (Q: Dec. 2024 )	-	Earnings per Share (Diluted) (Q: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2023 )) \|
=	(-0.003	-	-0.006)	/	\| -0.006 \|
=	50.00 %

Actinogen Medical YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinogen Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

3AC:Germany

Address

109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000

Website

https://www.actinogen.com.au

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.

Actinogen Medical Headlines

From GuruFocus

Stocks That Are Making A Good Come Back

By reports.droy reports.droy • 03-10-2015

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish • 10-13-2014